EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Association of High‐Grade Components < 20% on DFS in Stage I Lung Adenocarcinoma: A Real‐World Study of Risk Analysis and Predictive Nomogram Development

Shuhao Liang, Xuanpeng Wu, Tao Jiang, Ming Ni, Fei Xue, Chenxi Li, Tianhao Chen, Leyu Hong, Chao Luo, Qifei Wu iD

Cancer Medicine · 2026-11 · 15 (11)

DOI: 10.1002/cam4.72439 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 01.11.2026. Verfasst von Shuhao Liang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, China. Hauptthemen laut MEDLINE: Nomograms, Lung Neoplasms, Adenocarcinoma of Lung. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Key Research and Development Program of Shaanxi Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To assess whether high‐grade components occupying < 20% of the tumor have prognostic value and whether an Adjusted Grade nomogram improves risk stratification in Stage I invasive lung adenocarcinoma (LUAD).

Methods

We retrospectively analyzed 1539 patients with pathologically confirmed Stage I invasive LUAD undergoing R0 resection; 1321 with follow‐up, including 967 with preoperative CT. Tumors were classified by IASLC Grade and reclassified according to predominant pattern and high‐grade components; Adjusted Grade 3 was subdivided into MHGC ≤ 5%, DHGC > 5% to < 20%, and SHGC ≥ 20%. Cox models identified DFS predictors. Nomograms were internally validated with 1000 bootstrap resamples and assessed for discrimination, calibration, and net benefit.

Results

During a median 38‐month follow‐up, 124 DFS events occurred. Adjusted Grade 3 independently predicted recurrence (HR 3.07, 95% CI 1.54–6.12), while MHGC and DHGC were associated with poorer DFS (HR 3.95, 95% CI 1.53–10.15; HR 2.55, 95% CI 1.12–5.80). In the CT subgroup, consolidation‐to‐tumor ratio (CTR) independently predicted DFS (HR 3.08, 95% CI 1.46–6.51). Optimism‐corrected C‐index was 0.740 for the Adjusted Grade‐based nomogram, compared with 0.727 for the IASLC‐based nomogram and 0.612 for TNM staging. After adding CTR, they were 0.763 and 0.745 for the Adjusted Grade‐ and IASLC‐based nomogram. Decision‐curve analysis showed similar net benefit profiles for the two nomograms.

Conclusion

High‐grade components below 20% were associated with poorer DFS. The Adjusted Grade‐based nomogram improved internal discrimination versus IASLC Grade and TNM staging but showed no clear clinical‐benefit advantage over IASLC Grade. External validation is needed to establish optimal thresholds and clinical utility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NomogramsLung NeoplasmsAdenocarcinoma of LungHumansFemaleNeoplasm StagingMaleAgedRetrospective StudiesNeoplasm GradingMiddle AgedRisk AssessmentPrognosisDisease-Free SurvivalNeoplasm Recurrence, Local

Stichwörter der Autor:innen

IASLC gradeStage I lung adenocarcinomaadjusted gradedisease‐free survivalhigh‐grade componentsnomogram

Autor:innen und Institutionen

  • Department of Thoracic Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, China.

ORCID-Profile: Qifei Wu

Förderung

  • Key Research and Development Program of Shaanxi Province
  • National Natural Science Foundation of China

Zitieren

APA

Liang, S., Wu, X., Jiang, T., Ni, M., Xue, F., Li, C., Chen, T., Hong, L., Luo, C., & Wu, Q. (2026). Association of High‐Grade Components < 20% on DFS in Stage I Lung Adenocarcinoma: A Real‐World Study of Risk Analysis and Predictive Nomogram Development. Cancer Medicine, 15(11). https://doi.org/10.1002/cam4.72439

Vancouver

Liang S, Wu X, Jiang T, Ni M, Xue F, Li C, et al. Association of High‐Grade Components < 20% on DFS in Stage I Lung Adenocarcinoma: A Real‐World Study of Risk Analysis and Predictive Nomogram Development. Cancer Medicine. 2026;15(11). doi:10.1002/cam4.72439

BibTeX
@article{Liang2026,
  author = {Liang, Shuhao and Wu, Xuanpeng and Jiang, Tao and Ni, Ming and Xue, Fei and Li, Chenxi and Chen, Tianhao and Hong, Leyu and Luo, Chao and Wu, Qifei},
  title = {Association of High‐Grade Components < 20% on DFS in Stage I Lung Adenocarcinoma: A Real‐World Study of Risk Analysis and Predictive Nomogram Development},
  journal = {Cancer Medicine},
  year = {2026},
  volume = {15},
  number = {11},
  doi = {10.1002/cam4.72439}
}
Kostenlos starten →